Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 924 | 916 | 937 | 1286 | 1340 | 2498 |
Fund Return | -7.55% | -8.41% | -6.35% | 8.75% | 6.02% | 9.59% |
Place in category | 141 | 246 | 131 | 100 | 46 | 33 |
% in Category | 42 | 67 | 44 | 27 | 17 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MG Japan Fund Sterling I Acc | 3.72B | 12.18 | 11.00 | 10.27 | ||
MG Japan Fund Sterling I Inc | 3.72B | 12.19 | 11.00 | 10.27 | ||
MG Japan Fund Sterling R Acc | 3.72B | 11.93 | 10.73 | 9.99 | ||
MG Japan Fund Sterling R Inc | 3.72B | 11.93 | 10.72 | 9.99 | ||
MG Managed Growth Fund Sterling I A | 1.02B | 11.46 | 8.61 | 8.92 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPEurope Strategic Value Fund A dig | 1.42B | 8.07 | 8.60 | 5.67 | ||
European Value Fund D2g | 124.8M | 13.05 | 9.71 | 6.68 | ||
Brandes European Value Fund A GBP A | 692.84M | 11.59 | 11.63 | 7.64 | ||
Brandes European Value Fund I GBP A | 692.84M | 12.61 | 12.57 | 8.24 | ||
Funds European Equity Class Zg | 48.72M | 3.17 | 7.04 | 5.28 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 3.82 | 87.74 | -0.36% | |
Roche Holding Participation | CH0012032048 | 3.69 | 253.20 | -0.90% | |
TotalEnergies SE | FR0000120271 | 3.39 | 53.36 | -0.02% | |
BP | GB0007980591 | 3.24 | 395.95 | -0.28% | |
Securitas B | SE0000163594 | 2.45 | 137.85 | +0.25% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review